The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 02, 2023

Filed:

Dec. 07, 2021
Applicant:

Men Hwei Tsai, Duarte, CA (US);

Inventor:

Men Hwei Tsai, Alhambra, CA (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 7/06 (2006.01); C07K 14/47 (2006.01); A61P 25/28 (2006.01); A61K 47/18 (2017.01); A61K 33/30 (2006.01); A61P 35/00 (2006.01); A61K 38/08 (2019.01); C07K 4/12 (2006.01);
U.S. Cl.
CPC ...
C07K 14/4702 (2013.01); A61K 33/30 (2013.01); A61K 38/08 (2013.01); A61K 47/183 (2013.01); A61P 25/28 (2018.01); A61P 35/00 (2018.01); C07K 4/12 (2013.01); C07K 7/06 (2013.01);
Abstract

The present invention is generally directed to chemically synthesized peptides that are charged with zinc ions (herein 'zinc-charged peptides'). The chemically synthesized peptides are based on the amino acid sequence of alpha-lactalbumin. The present invention is further directed to a method of preparing these two zinc-charged peptides by charging the chemically synthesized peptides with zinc ions. It is observed that charging these peptides with zinc ions activate the peptide's ability to induce apoptosis in cancer cell lines, as well as increase ATP, reduce Tau protein and inhibit P38 in the brain. The zinc-charged peptides are thus capable of treating cancer and diseases involving tauopathy such as Alzheimer's Disease. The present invention is thus further directed to a method of treating cancer and diseases involving tauopathy such as Alzheimer's Disease using the zinc-charged peptides.


Find Patent Forward Citations

Tsai, Men. (2023). Zinc-charged peptides for the treatment of cancer and alzheimer's disease (U.S. Patent No. 11639372). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11639372

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…